TGTX vs. MIRM
Compare and contrast key facts about TG Therapeutics, Inc. (TGTX) and Mirum Pharmaceuticals, Inc. (MIRM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TGTX or MIRM.
Correlation
The correlation between TGTX and MIRM is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TGTX vs. MIRM - Performance Comparison
Key characteristics
TGTX:
1.55
MIRM:
1.52
TGTX:
2.40
MIRM:
2.22
TGTX:
1.29
MIRM:
1.27
TGTX:
1.05
MIRM:
2.29
TGTX:
11.08
MIRM:
6.57
TGTX:
9.48%
MIRM:
10.87%
TGTX:
63.46%
MIRM:
53.82%
TGTX:
-100.00%
MIRM:
-63.78%
TGTX:
-99.98%
MIRM:
-14.90%
Fundamentals
TGTX:
$5.98B
MIRM:
$2.18B
TGTX:
$0.25
MIRM:
-$1.85
TGTX:
20.74
MIRM:
6.48
TGTX:
30.68
MIRM:
9.68
TGTX:
$265.53M
MIRM:
$267.67M
TGTX:
$232.41M
MIRM:
$203.85M
TGTX:
$57.77M
MIRM:
-$33.56M
Returns By Period
In the year-to-date period, TGTX achieves a 12.49% return, which is significantly higher than MIRM's 9.41% return.
TGTX
12.49%
-4.70%
21.36%
97.78%
12.51%
8.27%
MIRM
9.41%
15.06%
10.13%
80.67%
22.10%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TGTX vs. MIRM — Risk-Adjusted Performance Rank
TGTX
MIRM
TGTX vs. MIRM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for TG Therapeutics, Inc. (TGTX) and Mirum Pharmaceuticals, Inc. (MIRM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TGTX vs. MIRM - Dividend Comparison
Neither TGTX nor MIRM has paid dividends to shareholders.
Drawdowns
TGTX vs. MIRM - Drawdown Comparison
The maximum TGTX drawdown since its inception was -100.00%, which is greater than MIRM's maximum drawdown of -63.78%. Use the drawdown chart below to compare losses from any high point for TGTX and MIRM. For additional features, visit the drawdowns tool.
Volatility
TGTX vs. MIRM - Volatility Comparison
TG Therapeutics, Inc. (TGTX) has a higher volatility of 20.55% compared to Mirum Pharmaceuticals, Inc. (MIRM) at 15.71%. This indicates that TGTX's price experiences larger fluctuations and is considered to be riskier than MIRM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
TGTX vs. MIRM - Financials Comparison
This section allows you to compare key financial metrics between TG Therapeutics, Inc. and Mirum Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TGTX vs. MIRM - Profitability Comparison
TGTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, TG Therapeutics, Inc. reported a gross profit of 92.79M and revenue of 108.19M. Therefore, the gross margin over that period was 85.8%.
MIRM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Mirum Pharmaceuticals, Inc. reported a gross profit of 76.63M and revenue of 99.41M. Therefore, the gross margin over that period was 77.1%.
TGTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, TG Therapeutics, Inc. reported an operating income of 29.95M and revenue of 108.19M, resulting in an operating margin of 27.7%.
MIRM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Mirum Pharmaceuticals, Inc. reported an operating income of -24.22M and revenue of 99.41M, resulting in an operating margin of -24.4%.
TGTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, TG Therapeutics, Inc. reported a net income of 23.33M and revenue of 108.19M, resulting in a net margin of 21.6%.
MIRM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Mirum Pharmaceuticals, Inc. reported a net income of -23.79M and revenue of 99.41M, resulting in a net margin of -23.9%.